$KBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HUMANIGEN, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HUMANIGEN, INC. Get notifications about new insider transactions in HUMANIGEN, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 5,231 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 341,236 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 11,226 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 2,851 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 185,996 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Option Exercise | C | 0.00 | 6,118 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 1,392 | 0 | 31,415 | 30 K to 31.4 K (+4.64 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 93,129 | 0 | 2,072,914 | 2 M to 2.1 M (+4.70 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 742 | 0 | 43,767 | 43 K to 43.8 K (+1.72 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 2,918 | 0 | 30,023 | 27.1 K to 30 K (+10.77 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 195,088 | 0 | 1,979,785 | 1.8 M to 2 M (+10.93 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 1,555 | 0 | 43,025 | 41.5 K to 43 K (+3.75 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 3,440 | 0 | 27,105 | 23.7 K to 27.1 K (+14.54 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 229,904 | 0 | 1,784,697 | 1.6 M to 1.8 M (+14.79 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 1,833 | 0 | 41,470 | 39.6 K to 41.5 K (+4.62 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 9,982 | 0 | 23,665 | 13.7 K to 23.7 K (+72.95 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 653,356 | 0 | 1,554,793 | 901.4 K to 1.6 M (+72.48 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 19,120 | 0 | 39,637 | 20.5 K to 39.6 K (+93.19 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 5,231 | 0 | 13,683 | 8.5 K to 13.7 K (+61.89 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 341,236 | 0 | 901,437 | 560.2 K to 901.4 K (+60.91 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 11,226 | 0 | 20,517 | 9.3 K to 20.5 K (+120.83 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 2,851 | 0 | 8,452 | 5.6 K to 8.5 K (+50.90 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 185,996 | 0 | 560,201 | 374.2 K to 560.2 K (+49.70 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | SOFINNOVA VENTURE PARTNERS V L ... | 10% Owner | Buy | C | 0.00 | 6,118 | 0 | 9,291 | 3.2 K to 9.3 K (+192.81 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,207 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 80,731 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 643 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,565 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 171,450 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,367 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 3,143 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 210,056 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 1,675 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 9,982 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 653,356 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 19,120 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 5,231 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 341,236 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 11,226 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,851 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 185,996 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 6,118 | 0 | 0 | |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,392 | 0 | 31,415 | 30 K to 31.4 K (+4.64 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 93,129 | 0 | 2,072,914 | 2 M to 2.1 M (+4.70 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 742 | 0 | 43,767 | 43 K to 43.8 K (+1.72 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,918 | 0 | 30,023 | 27.1 K to 30 K (+10.77 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 195,088 | 0 | 1,979,785 | 1.8 M to 2 M (+10.93 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,555 | 0 | 43,025 | 41.5 K to 43 K (+3.75 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 3,440 | 0 | 27,105 | 23.7 K to 27.1 K (+14.54 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 229,904 | 0 | 1,784,697 | 1.6 M to 1.8 M (+14.79 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,833 | 0 | 41,470 | 39.6 K to 41.5 K (+4.62 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 9,982 | 0 | 23,665 | 13.7 K to 23.7 K (+72.95 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 653,356 | 0 | 1,554,793 | 901.4 K to 1.6 M (+72.48 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 19,120 | 0 | 39,637 | 20.5 K to 39.6 K (+93.19 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 5,231 | 0 | 13,683 | 8.5 K to 13.7 K (+61.89 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 341,236 | 0 | 901,437 | 560.2 K to 901.4 K (+60.91 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 11,226 | 0 | 20,517 | 9.3 K to 20.5 K (+120.83 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 2,851 | 0 | 8,452 | 5.6 K to 8.5 K (+50.90 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 185,996 | 0 | 560,201 | 374.2 K to 560.2 K (+49.70 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | C | 0.00 | 6,118 | 0 | 9,291 | 3.2 K to 9.3 K (+192.81 %) |
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | Lehman Brothers Holdings Inc. | Option Exercise | C | 0.00 | 974,940 | 0 | 0 | ||
Feb 07 2013 | KBIO | KALOBIOS PHARMACEU ... | Lehman Brothers Holdings Inc. | Buy | C | 0.00 | 1,067,059 | 0 | 1,067,059 | 0 to 1.1 M | |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | GBS Venture Partners Pty, Ltd | 10% Owner | Buy | P | 8.00 | 25,000 | 200,000 | 25,000 | 0 to 25 K |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | Smith Brigitte | Director | Buy | P | 8.00 | 25,000 | 200,000 | 25,000 | 0 to 25 K |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | 5AM Partners LLC | 10% Owner | Buy | P | 8.00 | 62,500 | 500,000 | 223,190 | 160.7 K to 223.2 K (+38.89 %) |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 5,485 | 43,880 | 5,601 | 116 to 5.6 K (+4,728.45 %) |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 366,592 | 2,932,736 | 374,205 | 7.6 K to 374.2 K (+4,815.34 %) |
Feb 04 2013 | KBIO | KALOBIOS PHARMACEU ... | HEALY JAMES | Director | Buy | P | 8.00 | 2,923 | 23,384 | 3,173 | 250 to 3.2 K (+1,169.20 %) |